Intramuscular Whether given intramuscularly (IM) or subcutaneously (SQ), the goal of B12 injections is to bypass the digestive system when stomach absorption of B12 is impaired
BPC-157 is not FDA approved as a standard medication, and the FDA has identified concerns around compounded BPC-157, including possible immunogenicity risk, peptide-related impurities, and limited safety information for certain routes of administration
The factors have proadhesive, proinflammatory, and prothromobic roles, all of which become pertinent after vascular injury (Schweighofer et al., 2007
Patients with complex medical histories, unexplained symptoms, pregnancy considerations, immune disorders, active cancer concerns, severe allergies, medication interactions, or competitive sport obligations should avoid self-directed use and seek medical guidance